US 12350285
Compounds and methods for reducing ATXN3 expression
granted A61KA61K31/7115A61K31/7125
Quick answer
US patent 12350285 (Compounds and methods for reducing ATXN3 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/7115, A61K31/7125, A61P, A61P25/28